Guide Therapeutics

About:

Guide Therapeutics is a biotechnology company solving the challenge of delivery of genetic therapies.

Website: https://guidetx.com/

Top Investors: GreatPoint Ventures

Description:

Guide Therapeutics is a biotechnology company that solves the challenge of delivery of genetic therapies. The company patented technologies to test thousands of chemically distinct nanoparticles in vivo. This enables them to identify simple, scalable, and clinically relevant nanoparticles that target new cell types efficiently and safely. It pioneers new gene therapies by developing field-leading drug delivery vehicles. Guide Therapeutics is using a proprietary screening platform that performs thousands of drug delivery experiments directly in vivo, they identify nanoparticles that deliver DNA or RNA to cell types others cannot reach.

Total Funding Amount:

$13.9M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Tucker, Georgia, United States

Founded Date:

2018-01-01

Contact Email:

contact(AT)guidetx.com

Founders:

Cory Sago, James Dahlman

Number of Employees:

11-50

Last Funding Date:

2020-08-11

IPO Status:

Private

Industries:

© 2025 bioDAO.ai